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INTRODUCTION
The 1,2,4-triazole(4H) derivatives, which are 
used in this study, play an important role in medic-
inal chemistry and are useful templates for further 
development through modification or derivatiza-
tion to design more potent biologically active com-
pounds. 1,2,4-Triazole is an important group in het-
erocyclic compounds because of wide range of thera-
peutically importance used in a wide variety of med-
icines e.g. Ribavarin, (an antiviral drug), Rizatriptan 
(an antimagraine), Alprazolam (an anxiolytic), Vo-
rozole, Letrozole and Anastrozole (antitumoral) are 
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In this work, the series of new 4-phenyl-5-4-(R)-phenoxymethyl-1,2,4-triazole-3-ylthio-1-(R1)-acetophe-
nones have been synthesized by alkylation of correspondent 4-phenyl-5-phenoxymethyl-3-mercapto-1,2,4-
triazoles (4H) with the α-chloroacetophenones. The structure of the synthesized substances has been prov-
en by NMR spectra. High possibility of anti-ulcer and anti-helicobacter activity was determined by the PASS 
program. Molecular docking and anti-ulcer screening of new 1,2,4-triazole(4H) derivatives on the acute al-
cohol-prednisolone model NSAID-inducеd ulcers in rats has been performed.
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some examples of these drugs (1). A large number of 
research has been carried out on 1,2,4-triazole(4H) 
and their derivatives, which have proved the phar-
macological importance of these heterocyclic nucle-
us (2-6). Although they have been known from long 
ago as biologically active, their varied biological fea-
tures are still interesting for science. An addition-
al advantage of this group of substances is the rela-
tive simplicity of their synthesis. Previously, we have 
synthesized derivatives of 3-mercapto-1,2,4-triazole 
containing in 5 position phenoxymethyl and in 4 
position benzyl or allyl residues (7-8). A number of 
them have shown interesting pharmacological prop-
erties, one of them has anti-ulcer activity (7-8). We 
were interested to see how the replacement of benzyl 
or allyl residues to phenyl in 4 position influences on 
the pharmacological properties. The purpose of this 
work is the synthesis of new derivatives of 1,2,4(4Н) 
triazoles, prediction of their probable anti-ulcer ac-
tivity by the computer program PASS, conducting 
the docking study, and comparison of their anti-ul-
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cer activity in vivo on the acute alcohol-prednisolone 
model NSAID-inducеd ulcers in rats. 
MATERIALS AND METHODS
Synthetic strategy of this study is the struc-
ture modification of 1,2,4-triazole(4H) ring scaf-
folds in the positions 1, 2 and 5 with the aim of ob-
taining more potent pharmacologically active com-
pounds. All research chemicals were purchased from 
the Sigma-Aldrich (USA) and used as such for the re-
actions. Several key types of the reactions were gener-
ally used us that allowed to obtain new started mer-
captotriazoles 6a-b (9). The synthesis of 6a-b was car-
ried out from the corresponding phenols 1a-b due to 
Scheme 1. 
Resulting from the alkylation of ethyl chloro-
acetate and subsequent hydrazinolysis substituted 
phenoxyacetic acid hydrazides 3a-b were involved 
into interaction with phenylisothiocyanates 4 with 
vigorous stirring in ethanol. Reactions were moni-
tored by thin layer chromatography carried out using 
pre-coated silica gel plates (E. Merck and Co., Darm-
stadt, Germany).
The reaction mixture was heated to reflux, 
cooled and the precipitate of formed substituted 
phenylthiosemicarbazides 5a-b was filtered out and 
dried. Phenylthiosemicarbazides synthesized were 
cyclized in the presence of alkali. The reaction mix-
ture was refluxed. After cooling, the solution was 
acidified with hydrochloric acid to pH = 3-4. The 
resulting precipitate was the corresponding 4-aryl-
5-phenoxymethyl-3-mercapto-1,2,4-triazoles 6a-b 
was filtered, washed with water and dried. The ex-
istence of thiol-thione tautomerism is known for the 
compounds 6a-b, and thione forms predominates 
according to the data of NMR spectroscopy. To fur-
ther transformations mercaptotriazoles synthesised 
6a-b were alkylated by chloroacetophenones 7a-f 
in a homogeneous base catalysis conditions, result-
ing to the compounds 4-phenyl-5-4-(R)-phenoxy-
methyl-1,2,4-triazole-3-ylthio-1-(R1)-acetophenones 
8a-f (Scheme 1). Structures of compounds were con-
firmed via their spectral data. The 1H NMR spec-
tra were obtained on an NMR Spectrophotometer 
(Bruker Avance II 200 NMR) using DMSO-d6 as a 
solvent. Chemical shifts were expressed in parts per 
million relative to TMS as an internal standard. 
All substances 8a-f  have been tested for com-
pliance with Lipinski’s rule of five (a set of physical 
Scheme 1
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and chemical properties meet modern requirements 
that apply to new compounds under testing their bi-
ological activity) by the computer program ACD 
/ Labs (10). The probability of anti-ulcer activity of 
the newly synthesized substances was simulated by 
the computer program PASS (Prediction of Activity 
Spectra for Substances) (11). 




)-acetophenones have been per-
formed. Docking was carried out by taking of pro-
teins membrane histamine H
2
 receptor (PDB ID: 
1U19), human gastric pathogen helicobacter pylori 
(PDB ID: 3 UX4) and the human microsomal pros-
taglandin E enzyme synthase 1(MPGES1) domains 
(PDB ID: 3DWW) as a targets for anti-ulcer activi-
ty (12-15). Since Black et al. first defined the H
2
R re-
ceptor and its involvement in gastric acid secretion, 
H
2
R antagonists (e.g., cimetidine, ranitidine, famoti-
dine) have been developed and used clinically as an-
tiacid secretagogues. These histamine H
2
R antago-
nists have revolutionized the treatment of peptic ul-
cers with their prominent therapeutic effects. Pros-
taglandins have anti-secretory effect on gastric acid 
and protect the lining of the stomach from the dam-
aging effects of the acid. Therefore, ligands which 
can prevent rapid metabolic conversion prostaglan-
dins into inactive products may be used for treating 
of NSAID-inducеd ulcer. Half the world’s popula-
tion is chronically infected with Helicobacter pylori, 
causing gastritis, gastric ulcers and an increased inci-
dence of gastric adenocarcinoma. Therefore, human 
gastric pathogen helicobacter pylori (PDB ID: 3UX4) 
also can be used as target. The docking simulations 
were performed by the SCIGRESS program (16). Fast 
docking method, in which receptor is rigid and li-
gands are flexible, was adopted and binding energy 
values were compared with each other. 
All chemical structures 8a-f were generated us-
ing ISIS DRAW 4.0 software. The docking study was 
performed using Scigress Explorer 7.7 installed on 
a single machine running on a 3.4 GHz Intel Core 
2 Duo Processor with 1GB RAM and 160 GB Hard 
Disk with Windows XP as Operating System. Li-
gands structures 8a-f were drawn on Scigress Ex-
plorer using standard bond, lengths and angles. The 
ligands were stored in .csf format. The proteins mod-
eled using the electron crystallographic structure at 
3.5Å resolution was downloaded from the RCSB Pro-
tein Data Bank (PDB ID: 1U19, 3DWW, 3UX4). Be-
fore the docking water molecules were removed and 
hydrogen was added to the crystal structure of pro-
teins. After assigning charge and protonation state 
final refinement (energy minimization) was done us-
ing MM3 force field runs. Energy minimization or 
complex optimization was done for molecular dock-
ing calculations and to optimize geometries within 
the binding site. Complex optimization gave us li-
gands with minimum energy pose within the active 
site cavity of the proteins. At the end of the docking 
study, the minimum Consensus scores for the best 
positions for each of ligands were obtained.
 Obtained 6 heterocyclic compounds became 
an object for study concerning anti-ulcer activity (17).
The study of anti-ulcer activity of the synthesized 
compounds was carried out using mongrel white rats 
of both sexes weighing 180-280 g, which previously 
were stood in a starvation diet for 24 hours without 
limitation of drinking water. Acute ethanol-prednis-
olone gastric ulcer of rats was induced by disposable 
intragastric administration of ethanol - prednisolone 
mixture (prednisolone at a dose of 20 mg/kg and eth-
anol (80 %) at the rate of 0.6 ml per 100 g of rat).
The test substance was administered intragas-
trically at a dose (20 mg/kg), a reference drug – ra-
nitidine at a dose 40 mg/kg in a preventive mode for 
1 hour prior to administration ethanol – predniso-
lone mixture. At the end of the experiment the ani-
mals were taken out of the experiment (24 hours af-
ter administration of ulcerogenic agent) under con-
ditions of euthanasia. The stomachs were removed, 
cut, washed with saline and conducted macroscop-
ic study of the gastric mucosa. Assessment of inten-
sity of ulcerative lesions and anti-ulcer activity of the 
preparations was carried out by the state of macro-
scopic parameters of the mucous membrane of the 
stomach and gastrointestinal tract, and the intensity 
of the formation of ulcer:
1. The percentage of animals with ulcers (PA);
2. The average size of ulcers in a group (SU);
3. Ulcer Index (UI);
4. Anti-ulcer activity (AUA, %).
Furthermore, in the process of analyzing the 
experimental results, external appearance and gen-
eral condition of the animals were taken into ac-
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count. Indicators of the state of the gastrointestinal 
tract and mucous membrane of the stomach, namely 
a swelling of the stomach and intestines, hyperemia, 
hemorrhage, edema, folding disorders were assessed 
for their severity in points:
0 points – there is no sign, 1 points – the sign is 
weak, 2 points – moderate, 3 points – much.
Ulcerative index and anti-ulcer activity were 
calculated by the formula:
UI = (SU × PA)/100
AUA, %=100% - ((UI (t) ×100%)/ UI(c)), where 
UI (t) –UI in the group of animals with model 
pathology, which are treated,
UI (c) – UI in the group of animals with control 
pathology, which are not treated.
Ranitidine was chosen as the reference 
drug, the active ingredient of which is N-[2-[[[5-
[(dimethylamine)methyl]-2-phuranil]thio]aethyl]-
N’-methyl-2-nitrо-1,1-ethendiamine (18). Raniti-
dine is included in the National Drug Formulary - 
namely the list of drugs for the treatment of peptic 
ulcer disease and its experimental dose has been tak-
en from the literature (18). The experimental dos-
es of the test substances are corresponded to previ-
ously established conditionally therapeutic dose of 
thiotriazoline.
RESULTS 




acetophenone 8a-f after crystallization from etha-
nol are white crystalline substances with clear melt-
ing points, soluble in organic solvents. Melting points 
(mp) were determined on a Kofler melting point ap-
paratus. Physical properties and other data are 
shown in Table 1. The structure of compounds 8a-f 
was confirmed by 1H NMR spectroscopy (19). The 
mercaptogroup proton signal after alkylation disap-
pears in compounds 8a-f. The signals of aromatic 
protons were observed in the ranges 6.75–8.20 ppm. 
As shown in Table 2, the signals of both methylene 
groups associated with sulfur and oxygen atom are 
common and occur. Due to the absence of protons 
in their surroundings they look like singlet. The sig-
nals of methylene groups have been interpreted by us 
in accordance with the electronegativity of neighbor-
ing atoms so – signals at 5.28-5.29 ppm has been at-
tributed to the presence of a group OCH
2
; at 5.15-5.18 
ppm – group SCH
2
. Methyl groups of the tert-butyl 
residue are shown on the spectra as a single signal in-
tensity in 9 protons at 1.20-1.25 ppm.
We can presume on the base of the data ob-
tained by the computer program PASS that all com-
pounds of this group (8a-f) may exhibit high anti-ul-
cer probable activity (Pa) by inhibition of histamine 
H
2-receptor
 (from 0.52 to 0.69) and anti-helicobacter ac-
tivity (Pa from 0.50 to 0.65), which served as a prima-
ry screen and are listed in Table 3. The most prom-
ising substance 8b (maximum activity index 0.69) is 
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Table 1. Yields, melting points and elemental analysis data for new compound synthesized 8a-f
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Experimental groups, 
(n=6)
Amount of animals 
with ulcers in group, %





Intact control – – – –
Checksum pathology 100 59,5±2,12 59,50 –
Ranitidine 100 48,5±2,48* 48,51 18,49
8a 100 45,75±1,23*/** 45,75 16,60
8b 100 44,75±3,69*/** 44,75 21,60
8c 100 49,89±3,13* 39,89 20,02
8d 100 45,83±1,83* 45,83 16,04
8e 100 45,25±2,92*/** 45,25 16,29
8f 100 59,24±1,44* 59,45 –
Table 4. Anti-ulcer activity screening 8a-f on acute alcohol-prednizolon model NSAID-induced ulcers
* activity was not significant
The experimental results were processed by mathematical statistics using Student‘s t-test. Significant results are considered Р≤0,05.
Notes: n - number of animals in the group;
*Statistically significant differences in relation to the control group of pathology at the significance level p <0.05 (by Student‘s t-test); 
**Differences are statistically significant in relation to the group receiving ranitidine at significance level p <0.05 (by Student‘s t-test).
Com pound №







8a 0.52 0.65 -23,5 -39,9 -14,3
8b 0.69 0.62 -39,4  -79,3  -15,3  
8c 0.58 0.63 -25,2 -75,2 -15,2
8 d 0.55 0.62 -25,7 -50,5 -15,5
8 e 0.62 0.64 -23,1 -33,5 -13,5
8 f 0.61 0.61 -14,3 -24,3 -14,3
Table 3. Compound probable activity and dock score
Ar-H ОСН
2
, 2Н, s SCH
2
, 2Н, s
8a 6,81-7,98, m, 13H 5,29 5,18 1,25, t-Bu, 9Н, s
8b 6,75-7,84, m, 14H 5,28 5,15 1,25, t-Bu, 9Н, s
















8e 7,33-8,08,  dd, 4Н


























Table 2. 1H NMR spectral characteristics of the synthesized compounds 8a-f
Scripta Scientica Pharmaceutica, vol. 2, No. 2, 2015, pp. 46-52
Copyright © Medical University of Varna
  51
Lina Perekhoda, Idibeg Kadamov, Narzullо Saidov et al.
taneously tert-butyl substituent and a nitro group 
(Table 3). All synthesized compounds 8a-f have no 
violations of Lipinski’s rule of five and can be recom-
mended for further research as compounds with fa-
vorable physical and chemical properties. 
The target proteins structures (PDB ID: 
1U19, 3DWW, 3UX4) were docked with new 
1,2,4-triazole(4H) derivatives 8a-f which provided 
excellent results as were seen by the least values of 
the dock score in Table 3. 
Anti-ulcer activity preliminary screening re-
sults for tested compounds at one dose assay are 
shown in Table 4. The studies found that 5 of the 6 
tested substances have anti-ulcer activity at the level 
of the reference drug ranitidine.
DISCUSSION
All prescreened ligands 4-phenyl-5-4-(R)-
phenoxymethyl-1,2,4-triazole-3-ylthio-1-(R1)-aceto-
phenones had docking scores in the receptor cavi-
ty (1U19) greater than that of ranitidine (-35.84 kcal/
mol) indicating that they bind the target better.
Results of the docking have shown that mole-
cule 8b has a dock score better in the receptor cavity 
(1U19) than the others (highest negative dock score - 
79.3) (Fig. 1). 
It means that it can fit well forming the most 
energetically stable drug receptor complex. The best 
possible binding modes of the 8b at targeted protein’s 
1U19 active sites are displayed in Fig. 2. 
All tested ligands had docking scores in the re-
ceptor cavity (3DWW) down the level of mysopro-
stol (-46.51 kcal/mol) indicating that they bind the 
target better. 
When analyzing the docking results it is worth 
to mention that compounds 1,2,4-triazole(4H) deriv-
atives 8a, 8b, 8c, 8d and 8e have anti-ulcer activity.
In our research experiment in vivo five deriva-
tives of 1,2,4-triazole (compounds tested 8a, 8b, 8c, 
8d and 8e) significantly prevented the gastric acid se-
cretion and gastric-ulcer formation, similar to the ra-
nitidine effect. Our results demonstrate that all test-
ed substances effectively inhibit gastric acid secre-
tion and protect the gastric mucosal layer in a man-
ner similar to that of other H
2
R antagonists.
Compound tested 8f in one-dose primary as-
say did not show any impressive anti-ulcer activi-
ty and therefore can’t be considered as prospective 
anti-ulcer agent. Results of studies have shown that 
utilization of phenoxymethyl and phenyl residue 
for the structure optimization of 1,2,4-triazole(4H) 
scaffolds is an effective approach in novel anti-ulcer 
agents design and may be taken as the variant of hy-
brid pharmacophore approach.
CONCLUSIONS
Overall, this work illustrated that 4-phenyl-
5-4-(R)-phenoxymethyl-1,2,4-triazole-3-ylthio-
1-(R1)-acetophenones have been synthesized by al-
kylation of initial 3-mercapto-4- phenyl -5- phenoxy-
methyl -1,2,4-triazole with cloroacetophenones. 
Fig. 1. Ligand 8b
Fig. 2. Protein 31U19 - Ligand 8b Interaction. Active site 
amino acid residues are represented as sticks colored 
according to residue type (Sequence protocol-Karplus and 
Schultz Flexibility).
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The structure of substances synthesized have been 
proved by elemental analysis and spectral data. Po-
tential anti-ulcer activity was found among new de-
rivatives 1,2,4-triazole(4H). Compound 8b was sub-
stantially more active than others and requires fur-
ther study. The studies confirmed compound 8b as 
a potent lead compound for drug discovery and fur-
ther optimization. 
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